Brugmann University Hospital is advancing cardiac surgery care with a new study evaluating the impact of combining Near Infrared Spectroscopy (NIRS) and SedLine® monitoring technologies. This clinical trial explores their potential to reduce postoperative cognitive disorders (POCD), a common concern following cardiac surgery, particularly in vulnerable patients.
Published on December 8, 2025, this initiative aims to provide actionable insights for healthcare professionals, regulatory bodies, and clinical teams.
In this article:
- What are postoperative cognitive disorders?
- What technologies are being studied?
- How might this study impact care?
- FAQ
- Conclusion
- Disclaimer
What are postoperative cognitive disorders?
Postoperative cognitive disorders (POCD) include a variety of cognitive impairments such as memory loss, difficulty concentrating, or reduced cognitive performance after surgery. Cardiac surgeries often involve complex procedures that may lead to these disorders due to factors like anesthesia, hypoxia, or other surgical stressors.
These disorders can significantly impact patients’ quality of life and prolong recovery. Identifying ways to prevent POCD remains a pressing goal for healthcare researchers worldwide.
What technologies are being studied?
Near Infrared Spectroscopy (NIRS)
NIRS technology measures brain oxygenation levels during surgery. Maintaining optimal oxygenation is critical to reducing neurological risks. NIRS provides real-time feedback to clinicians, allowing early intervention during events like desaturation.
SedLine® by Masimo
SedLine® monitors brain function under anesthesia by analyzing patient state index (PSi). Combining brain activity data with oxygenation metrics enables personalized anesthesia management, potentially minimizing risks that contribute to cognitive impairments.
Together, these technologies offer a combined approach to enhancing perioperative care and patient outcomes in high-risk procedures.
How might this study impact care?
This clinical trial from Brugmann University Hospital, currently recruiting participants, may offer critical data to validate the efficacy of combined SedLine® and NIRS monitoring approaches.
The dual-technology strategy is grounded in principles of patient safety and performance optimization supported by evidence-based monitoring. Results could guide regulatory devices assessment frameworks under guidelines like MDR Annex XIV, ensuring both safety and performance align with clinical needs.
The study represents a step forward for advancing perioperative care, potentially leading to new regulatory or clinical standards for cardiac surgery settings. It can emphasize the importance of incorporating multimodal monitoring techniques in modern surgical environments.
FAQ
- What is the purpose of the study?
To assess whether combining NIRS and SedLine® monitoring reduces the occurrence of postoperative cognitive disorders in cardiac surgery patients. - Who is conducting the study?
The study is sponsored by Brugmann University Hospital. - Is the study currently recruiting participants?
Yes, the trial is currently in the recruitment phase as of December 2025. - How do these devices improve patient care?
These tools provide real-time monitoring of brain oxygenation and activity, reducing complications and aiding quicker recovery.
Conclusion
The integration of advanced monitoring technologies like NIRS and SedLine® could present significant advances in managing cognitive risks during and after cardiac surgeries. Healthcare professionals and regulatory teams should closely follow the outcomes of this trial to evaluate broader adoption of these technologies.
Such innovations highlight the need for ongoing collaboration between clinical teams, technology developers, and regulatory frameworks to ensure effective solutions reach patients promptly.
Disclaimer
This article is for informational purposes only and does not constitute legal or professional regulatory advice. Always consult relevant guidelines and professionals before making clinical decisions.
Announcement
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07267416?term=medical+device